Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging

Gamal Anton Wakileh1, Christian Ruf2, Axel Heidenreich3

  • 1Department of Urology and Paediatric Urology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

World Journal of Urology
|November 15, 2021
PubMed
Abstract

Insights

Advanced imaging techniques can improve testicular germ cell tumor (TGCT) management by reducing overtreatment. Innovations in MRI and ultrasound offer better diagnostic accuracy for small lesions and residual masses, aiding treatment decisions.

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Testicular germ cell tumors (TGCTs) require careful management to minimize treatment burden.
  • Accurate diagnosis and staging are crucial to avoid overtreatment and improve outcomes.
  • Current imaging modalities face challenges in specific clinical scenarios.

Purpose of the Study:

  • To review the current state-of-the-art and innovative developments in TGCT imaging.
  • To address challenges in imaging small testicular lesions, lymph node staging, and post-chemotherapy residual masses.
  • To highlight imaging's role in guiding treatment decisions and reducing treatment burden.

Main Methods:

  • Selective literature search in PubMed, Medline, and conference proceedings.
  • Review of recent studies on advanced imaging techniques for TGCT.
  • Focus on challenging clinical situations in TGCT management.

Main Results:

  • Elastography, contrast-enhanced ultrasound, and MRI show promise for differentiating small testicular lesions.
  • FDG-PET-CT is unsatisfactory for borderline lymph nodes; nanoparticle-enhanced MRI is under investigation.
  • Diffusion-weighted MRI and radiomics are being explored for residual mass assessment; MRI is a non-inferior alternative to CT for stage I TGCT follow-up, avoiding radiation.

Conclusions:

  • Refining imaging techniques for TGCT is essential for guiding treatment decisions.
  • Improved imaging can significantly reduce treatment burden and enhance oncological outcomes.
  • Continued research into novel imaging modalities is critical for optimal TGCT patient care.

Related Concept Videos

Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
87
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Computed Tomography01:10

Computed Tomography

Tomography refers to imaging by sections. Computed tomography (CT) is a non-invasive imaging technique that uses computers to analyze several cross-sectional X-rays to reveal minute details about structures in the body.
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
7.0K